Cytokinetics shares owned by Ensign Peak Advisors
Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Ensign Peak Advisors
from 13F filings
Historical chart of Ensign Peak Advisors investment in Cytokinetics
Tip: Access up to 7 years of quarterly data
All positions including Cytokinetics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytokinetics by Ensign Peak Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $13M | 426k | 29.46 |
| 2023-06-30 | $12M | 351k | 32.62 |
| 2023-03-31 | $12M | 351k | 35.19 |
| 2022-12-31 | $16M | 343k | 45.82 |
| 2022-09-30 | $14M | 283k | 48.45 |
| 2022-06-30 | $9.3M | 238k | 39.29 |
| 2022-03-31 | $6.2M | 168k | 36.81 |
| 2021-12-31 | $7.2M | 158k | 45.58 |
| 2021-09-30 | $7.1M | 199k | 35.74 |
| 2021-06-30 | $4.0M | 203k | 19.79 |
| 2021-03-31 | $3.9M | 166k | 23.26 |
| 2020-12-31 | $1.5M | 74k | 20.78 |
| 2020-09-30 | $2.7M | 123k | 21.65 |
| 2020-06-30 | $1.8M | 74k | 23.58 |
| 2020-03-31 | $877k | 74k | 11.79 |
| 2019-12-31 | $699k | 66k | 10.61 |